NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients

Active Not RecruitingN/A

Sponsor: Beni-Suef University

Conditions: MCI

Interventions: SGLT2 Is+METFORMIN, DPP4 Is+metformin, Control group

Countries: Egypt

The study aims to investigate the effects of DPP-4 Is+ metformin versus SGLT2 Is + metformin on the risk of cognitive decline and depression in patients with T2DM.

Eligibility overview

Sex: ALL

Age: 55 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

\-

The study participants should meet the following inclusion criteria:

1. T2DM adult subjects (\>55 years old) will be eligible to participate.
2. Patients should be taking SGLT2Is+metformin or DDP4Is + metformin for at least 1 year to be eligible.

Exclusion Criteria:

1- Those with type1 diabetes or ketoacidosis, insulin therapy, end organ failure as chronic renal failure, liver, and heart failure, previous history of pancreatitis, history of Alzheimer's disease or any brain insult, and finally pregnant or lactating females will be excluded from the study.

Locations (1)

Banī Suwayf, Egypt